EconomyBelgium
GSK to Cut 1,217 Jobs in Belgium as Workers Block Sites
GSK plans to cut 1,217 jobs in Belgium, threatening its Wavre and Rixensart sites as workers block both plants in protest.
—6 min read
Tag
5 articles
GSK plans to cut 1,217 jobs in Belgium, threatening its Wavre and Rixensart sites as workers block both plants in protest.
GSK plans to cut up to 1,217 jobs in Wallonia, Belgium's largest collective redundancy this year, sparking union anger and political reaction.
GSK announces its largest-ever acquisition, buying US cancer biotech Nuvalent for $10.6 billion in a major oncology push under new CEO Luke Miels.
Phase III trials show bepirovirsen achieves functional cure in 19% of chronic hepatitis B patients, marking a major treatment advance.
Renewed labor tensions at GSK in Belgium as workers denounce reduced severance terms for six employees, calling the situation 'extremely worrying.'